Latest news with #cataract
Globe and Mail
08-07-2025
- Business
- Globe and Mail
Alcon's Latest Breakthrough Surgical Technology, Unity VCS, receives Health Canada approval
Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced that UNITY ® Vitreoretinal Cataract System (VCS) has received Health Canada approval. This innovation is the first to be introduced from Alcon's highly anticipated Unity portfolio. This press release features multimedia. View the full release here: UNITY® Vitreoretinal Cataract System (VCS) 'Today marks an important day for Canadian ophthalmologists as we introduce the next generation of equipment solutions in cataract and vitreoretinal surgery, and we are grateful to those who helped us reach this milestone,' said Franck Leveiller, Head of Global R&D and Chief Scientific Officer, Alcon. 'We have a long legacy of engaging our customers throughout the research and development process to design bold innovations in ophthalmology. This approval is a significant milestone in delivering meaningful impact for Canadian Eye Care Professionals and patients.' Unity VCS is Alcon's most advanced vitreoretinal and cataract surgical innovations combined together in one integrated platform. Unity VCS is designed to deliver enhanced workflow efficiencies over Alcon's current leading systems, CONSTELLATION ® Vision System for vitreoretinal and combined procedures, and CENTURION ® Vision System with ACTIVE SENTRY ® for cataract surgery. "The first time I used Unity VCS in a wet lab environment, I had a real 'wow' reaction," said Dr. Rosa Braga-Mele, ophthalmologist and chair of Alcon's North America Cataract Core Advisory Board. "This is a proud moment to see the world-class innovation from Alcon receive approval in Canada. I'm particularly excited about the stability of the fluidics and cutting efficiency of the platform, which is quite remarkable and will create considerable surgical efficiencies." Unity VCS leverages a novel phacoemulsification modality to deliver up to two times faster nucleus removal ^ with 40% less energy * into the eye 1, and a first-of-its-kind phaco handpiece that estimates temperature at the incision site 3. In vitreoretinal advancements, the new technology offers cutting speeds of up to 30,000 cuts per minute, the world's fastest vitrectomy probe #,2,3. The platform offers surgical stability and efficiency with a unique proprietary fluidics system 3. "As a global market leader in cataract and retina surgical products 4,5,6, Alcon recognizes that the increasing demand for these procedures 7,8,9 necessitates enhanced workflow efficiencies and excellent patient outcomes," said Jeroen Bastemeijer, General Manager, Alcon Canada. "Unity VCS builds on Alcon's expertise in surgical equipment with pioneering innovations for vitreoretinal and cataract surgery—driving advancements from cutting speeds to fluidics management, to ergonomics and workflow. We are thrilled to bring this latest breakthrough technology, Unity VCS, to Canadian clinics in 2026." Alcon has tested Unity VCS during investigational advisory wet lab sessions with more than 200 highly experienced surgeons from 30+ countries. Commercial launch of Unity VCS is expected in early 2026. Unity VCS is the latest innovation from the Alcon Vision Suite—a portfolio of innovative products designed to help Eye Care Professionals increase clinic and OR efficiency, and deliver exceptional patient experiences. The Alcon Vision Suite will continue to grow with cutting-edge Unity products that are expected to be introduced over the coming years, adding to our market-leading legacy products, which will continue to be available and serviceable. Unity VCS will be supported by Alcon's training, product maintenance, and Services teams. About Alcon Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people's lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 25,000 associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals and programs that advance access to quality eye care. Learn more at About UNITY VCS Indications / Intended Use 3: The UNITY ® VCS (Vitreoretinal Cataract System) console, when used with compatible devices, is indicated for use during anterior segment (i.e. phacoemulsification and removal of cataracts) and posterior segment (i.e. vitreoretinal) ophthalmic surgery. In addition, with the optional laser, this system is indicated for photocoagulation (i.e. vitreoretinal and macular pathologies), iridotomy and trabeculoplasty procedures. Please refer to the Directions for Use for the accessories/consumables and User Manual for a complete listing of indications, warnings, cautions and notes. ^2x faster nucleus removal than OZIL Torsional phaco *Based on N=10 HPs, Artificial cataract lens IOP 55 mmHg vacuum of 450 mmHg # Compared to Constellation HYPERVIT 20k vitrectomy probe OZIL - Trademarks are the property of their respective owners. References Alcon Data on File, 2024 - REF-24379. Alcon Data on File, 2024 - REF-24644. Unity VCS User Manual 2024 – REF-24980. Market Scope 2023 Retinal Surgical Device Market Report, 2023. Market Scope 2023 Cataract Surgical Equipment Market Report, 2023. Market Scope 2024 IOL Market Report, 2024. CNIB – Blindness in Canada, Accessed December 2, 2024 - REF-19527. The Prevalence of Canadian Vision Loss and Cataract Surgery, 2019 - REF-01661. Conference Board of Canada - Ophthalmology in Canada: Why Vision Loss Should Not Be Overlooked, 2020 - REF-10834.
National Post
20-06-2025
- Business
- National Post
Alcon Introduces Clareon PanOptix Pro in Canada, Delivering the Lowest Light Scatter of any Trifocal IOL
Article content Clareon PanOptix Pro has half the light scatter of Clareon PanOptix 1-3,*,** PanOptix Pro provides an unprecedented 94% light utilization, compared to a theoretical maximum utilization of 96% for diffractive optics 1-4,*,**,† Clareon PanOptix Pro provides more uninterrupted light distribution across the full visual range, and is designed for better image contrast 1,††,‡ Article content TORONTO — Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the approval of Clareon ® PanOptix ® Pro intraocular lens (IOL) for cataract patients inCanada. PanOptix Pro leverages proprietary ENLIGHTEN ® NXT Optical technology which delivers the lowest light scatter and highest reported light utilization of any trifocal IOL. 1-3,5-9,**,‡‡ PanOptix Pro provides an unprecedented 94% light utilization, compared to a theoretical maximum utilization of 96% for diffractive optics. 1-4,*,**,† These enhancements also provide more uninterrupted light distribution from distance to near, and a 16% increase in optical image contrast between distance and intermediate. 1,††,‡ PanOptix Pro builds on the clinically-proven low visual disturbance profile, high spectacle independence and exceptionally high patient satisfaction of PanOptix. 10-13,§,§§,¶,¶¶ 'Now, with PanOptix Pro, more light utilization and less light scatter is possible‡,‡‡, empowering both my practice and my patients.' Article content 'As the global leader in eye care, we are committed to improving our technologies to advance patient outcomes through rigorous, world-class R&D,' said Rob Scott, VP, Intraocular Devices, R&D, Alcon. 'Our team looked at hundreds of design options, ultimately landing on a targeted diffractive refinement that helped us recover 50% of light lost to scatter, and reposition it to a beneficial focal point for PanOptix Pro. 1,3,10.14-19,* This allowed for specific enhancements while maintaining the features that have driven the success of PanOptix—the world's most implanted trifocal IOL.' 1-3,20,21,*,**,‡‡,‖,Ω 'PanOptix has been a cornerstone of my cataract practice for eight years,' said Dr. Rosa Braga-Mele, MD, MEd, FRCSC, Professor of Ophthalmology, University of Toronto. 'These lenses have consistently delivered outstanding visual outcomes for my patients 10, 24, § – a low visual disturbance profile 25, ∂ and a happy patient with greater spectacle independence. 23, § So, it's exciting to see this technology evolve to further meet patients' visual expectations. Now, with PanOptix Pro, more light utilization and less light scatter is possible ‡,‡‡, empowering both my practice and my patients.' Article content PanOptix Pro will be available in Canada from Alcon in the single-use Clareon AutonoMe ® preloaded delivery system and as well as with the Clareon Monarch ® IV delivery system in early 2026. 22 PanOptix Pro offers a +2.17 diopter intermediate and a +3.25 diopter near add power. Like all Alcon IOLs, PanOptix Pro will be available with blue light and ultraviolet filtering. 22 For surgeons interested in more information on PanOptix Pro, please speak to a local Alcon representative. Article content About Clareon PanOptix Pro Article content The Clareon PanOptix Pro Trifocal IOL is a type of multifocal IOL used to focus images clearly onto the back of your eye (retina) to allow clear vision after the cataract removal. In addition, the center of the Clareon PanOptix Pro Trifocal IOL allows for better near (reading) vision and intermediate (computer work) vision versus what a monofocal lens would provide. Please consult the Directions for Use regarding indications, precautions, cautions and warnings which is available at Article content About Alcon Article content Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people's lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 25,000 associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals and programs that advance access to quality eye care. Learn more at Article content * PanOptix has 88% light utilization (12% scatter light)/PanOptix Pro 94% light utilization (6% scatter light). ** Based on manufacturer-reported values and respective methodology for Clareon PanOptix, Envista Envy, AT Elana, Gemetric and Rayner. † For feasible diffractive optics of up to pentafocal design from Krackhardt et al. †† Simulated photopic through-focus point spread function (light intensity [energy])—polychromatic. ‡ Compared to Clareon PanOptix. ‡‡ Based on bench and vision simulator studies. §Based on prospective multicenter randomized study at 6 months, significantly more subjects reported not experiencing starburst and glare (p<0.05 n=276). §§All-implanted analysis set. ¶In response to the IOLSAT questionnaire question 'In the past 7 days, how often did you need to wear eyeglasses to see'? ¶¶Response to the following question on IOLSAT questionnaire (Version 1.0, December 20, 2018) at 6 months post-op 'Given your vision today, if you had to do it all over, would you have the same lenses implanted again?'; n=127. ‖ Based on worldwide IOL unit sales of Clareon PanOptix and AcrySof IQ PanOptix through Q1, 2024. Ω Severity ratings by phakic patients with simulated implant of Clareon PanOptix Pro and Clareon PanOptix using VirtIOL simulator (n=64). ∂ Based in a meta-analysis of 11 unique clinical studies with 580 patients in 10 different countries, including 'very bothersome' and 'severe' visual disturbances. Clinical studies were performed on the AcrySof IQ PanOptix IOL; AcrySof IQ PanOptix and Clareon PanOptix are optically equivalent. Article content References Article content Alcon data on file, 2025. REF-25218 Alcon data on file, 2024. REF-25221 Alcon data on file, 2015. REF-08546 Krackhardt U, et al: Upper bound on the diffraction efficiency of phase-only fanout elements. Applied Optics; 1992; 31:27-37.; 10. Zhu D., Zhang J., et al. Patient-Reported Outcomes of Visual Disturbances with a Trifocal Intraocular Lens: A meta-analysis. Paper presented at: ASCRS Annual Meeting; April 5-8, 2024; Boston. Muzychuk, A. Defocus Curve Performance of a Novel Hydrophobic Acrylic Trifocal Intraocular Lens: A prospective, Multicenter Canadian Study. ASCRS Annual Meeting, April 5-8, Boston. Rayner Professional Website. Accessed September 2024. Carones F. New Concept of Light Distribution for Bilateral Trifocal IOL Implantation. AAO. 2022;2022:53. ZEISS AT LISA tri family. Supplement in Cataract and Refractive Surgery Today (Europe), September 2014. Zeiss Cataract Insights: Laying the Myth or Reality; Digitalization enhances cataract surgery? Supplement in Ophthalmology Times, Europe; May 22, 2024; Accessed September 2024. Kohnen T, Lapid-Gortzak R, Ramamurthy D, et al. Clinical outcomes after bilateral implantation of a diffractive trifocal intraocular lens: A worldwide pooled analysis of prospective clinical investigations. Clinical Ophthalmology. 2023;Volume 17:155-163. doi:10.2147/opth.s377234. Alcon data on file, 2024. REF-23958. Alcon data on file, 2018. REF-01475. Alcon Vision LLC. Clareon® PanOptix® Trifocal Hydrophobic Acrylic IOL. Product Information. 2021. Charness N, Dijkstra K, Jastrzembski T, Weaver S, Champion M. Monitor viewing distance for younger and older workers. Proceedings of the Human Factors and Ergonomics Society Annual Meeting. 2008;52(19):1614- 1617. doi:10.1177/154193120805201965 Government of Canada CC for OH and S. CCOHS: Office ergonomics. Canadian Centre for Occupational Health and Safety. April 25, 2023. Accessed May 9, 2023. Gundersen K, Potvin R. Trifocal intraocular lenses: A comparison of the visual performance and quality of vision provided by two different lens designs. Clinical Ophthalmology. 2017;Volume 11:1081-1087. doi:10.2147/opth.s136164 Kohnen T, Titke C, Böhm M. Trifocal intraocular lens implantation to treat visual demands in various distances following lens removal. American Journal of Ophthalmology. 2016;161. doi:10.1016/ Lwowski C, Pawlowicz K, Petermann K, et al. Visual and patient-reported factors leading to satisfaction after implantation of diffractive extended depth-of-focus and trifocal intraocular lenses. Journal of Cataract and Refractive Surgery. 2022;48(4):421-428. doi:10.1097/ Alcon data on file, 2024. REF-25903 Alcon data on file, 2024. REF-23554 MarketScope LLC. 2023 IOL Market Report: Global Analysis for 2022 to 2028. St. Louis, MO: MarketScope LLC; 2023. Clareon® PanOptix® Pro Trifocal Hydrophobic Acrylic IOL Model PXYWT0 2024 Directions for Use. Zhu D, et al. Rate of complete spectacle independence with a trifocal intraocular lens: A systematic literature review and meta-analysis. Ophthalmology and Therapy. 2023;12(2):1157-1171. doi:10.1007/ Vision LLC. Modi S, Lehmann R, Maxwell A, et al. Visual and patient-reported outcomes of a diffractive trifocal intraocular lens compared with those of a monofocal intraocular lens. Ophthalmology. 2021;128(2):197-207. doi:10.1016/ Zhu D., Zhang J., et al. Patient-Reported Outcomes of Visual Disturbances with a Trifocal Intraocular Lens: A meta-analysis. Paper presented at: ASCRS Annual Meeting; April 5-8, 2024; Boston. Article content Article content Article content Article content Article content Contacts Article content Media Relations Article content Article content Article content Article content
Health Line
04-06-2025
- General
- Health Line
Do You Need Glasses After Cataract Surgery?
Cataract surgery replaces the cloudy lens inside the eye with an artificial lens. Cataracts are common as you age, and surgery is usually safe and effective. Depending on your replacement lens, you may need glasses after cataract surgery. A cataract is a clouding of the natural lens inside the eye due to many different causes, like aging, toxic exposures, or injury. Cataract surgery is a procedure where the damaged lens of your eye is removed and replaced with an artificial lens implant. Cataracts become more common as you get older, and more than half of Americans over age 80 develop them. Cataract surgery is usually a safe and effective procedure, but you may need to wear glasses after the surgery, depending on what type of artificial lens is implanted. Who needs glasses after cataract surgery? The lens is a curved piece of clear tissue in your eye. Situated behind your pupil, it changes the way light enters your eye and helps you focus your vision at different distances. Cataract surgery involves replacing the lens in your eye with an artificial replacement called an intraocular lens (IOL). Whether you'll need glasses after cataract surgery largely depends on what type of IOL you get. There are many IOL options. Take the time to talk with your eye surgeon beforehand so that you make the choice that's right for you The main types of IOLs include: Monofocal: Monofocal IOLs are the most common, and also the only IOL that is usually covered by Medicare, Medicaid, and private health insurance. They focus at only one distance, either close, far, or intermediate range. Most people get them for distance vision. Multifocal: Multifocal IOLs provide both distant and near focus simultaneously. They contain different zones, shaped like concentric rings, that allow you to focus on objects far away and close up. Extended depth of focus: Extended depth of focus IOLs have only one corrective zone, which is stretched to allow distance and intermediate vision. Accommodative: Accommodative IOLs change shape like your eye's natural lens to allow you to focus at different distances. Toric: Toric IOLs correct astigmatism, a vision issue that's caused by an irregularly shaped cornea. Light-adjustable lens (LAL): This newer type of IOL is the only one that can be customized after surgery. Adjustments are done through a series of office-based light treatment procedures. In one 2017 study, 81% of subjects who had cataract surgery in both eyes regularly wore glasses before their procedure. After the procedure, only 49% regularly wore glasses. If you get a monofocal IOL, you'll need glasses or contacts to see outside your lens's focus range. For instance, if you opt for an IOL for distance vision, you may still need glasses for reading or to see things clearly up close. If you're having surgery in both eyes, you may have the option to choose monovision to reduce the need for glasses, especially if you have worn monovision contacts. Monovision involves selecting the focusing power of one IOL for distance and the other for near sight. If you get multifocal IOLs, you may find that your vision is still blurry when focusing at certain distances, and you may need to wear glasses to focus in this range. According to the American Academy of Ophthalmology, most people with accommodative IOLs don't need to wear glasses, but some people still prefer to do so for long periods of reading or activities that require near vision. What kind of glasses are needed after cataract surgery? The type of glasses you'll need after cataract surgery will depend on what type of IOL you receive. In the case of a monofocal IOL, most people receive an IOL with distance vision correction and wear glasses for reading and activities that involve near vision. Some people get IOL lenses for near vision and wear glasses for distance vision. However, if you have a fair amount or significant amount of astigmatism and did not get Toric IOL, you will need glasses for distance and near. If you have IOLs that allow you to focus at different distances, you may still find certain distances are blurry. In this case, you may want to wear glasses that allow you to see clearly at those distances. Frequently asked questions about glasses after cataract surgery How long should you wait before getting new prescription glasses after cataract surgery? It's important to wait for your eyes to fully heal and your vision to stabilize before getting a new prescription. You may be able to get new glasses as soon as 2 weeks after your surgery. It may be longer if you have swelling or other complications. It's important to wait for your eyes to fully heal and your vision to stabilize before getting a new prescription. You may be able to get new glasses as soon as 2 weeks after your surgery. It may be longer if you have swelling or other complications. Are there any signs that indicate you need new glasses? It's typical to have some blurriness and trouble seeing for a few days after cataract surgery. If you notice persistent changes to your vision, you may need to change your prescription. Some vision changes you might notice include: blurry vision squinting a lot tired eyes frequent headaches light sensitivity It's typical to have some blurriness and trouble seeing for a few days after cataract surgery. If you notice persistent changes to your vision, you may need to change your prescription. Some vision changes you might notice include: How do you know which glasses are right for you? After you've healed from your cataract surgery, your eye doctor will perform an updated refraction to determine which eyeglass prescription is best for you. It's most common that people who undergo cataract surgery will need reading glasses after their vision has stabilized. The bottom line Cataract surgery is typically a safe and effective procedure that can correct vision blurriness or cloudiness caused by cataracts. The most common type of replacement lens is a monofocal IOL. These lenses allow your eye to focus at only one distance: either near, far, or intermediate. Most people get monofocal IOLs for distance vision and wear glasses for reading. If you get multifocal lenses that allow you to see at multiple distances, you may not need glasses. If you're unsure about what type of IOL you need or whether you'll need glasses after cataract surgery, be sure to talk with your eye doctor.
ABC News
01-06-2025
- General
- ABC News
Cataract surgery blitz for Indigenous patients restores sight for hunting
In the operating theatre at Katherine Hospital, the team moves in silent unison. Scrub nurse Peter Mitchell anticipates which tool the surgeon will need next, as he carefully makes a small incision in a patient's eye. "Being in theatre in this situation, it's a really beautiful feeling — a real sense of flow and understanding," he says. But these are tricky cases. The patient on the table has a dense cataract that has gone untreated for some time. "Very, very seldom do you see a cataract as hard as this down south, but they're relatively common in the sorts of areas we're in now," Mr Mitchell says. Patients have been flown and driven into Katherine from remote communities across the Big Rivers region of the Northern Territory for an intensive week of surgeries, conducted by the Indigenous and Remote Eye Service. Over two days, cataracts will be removed from 27 eyes, in some cases bringing patients back from the brink of blindness. One of the patients is Mildred Hector, a Bilinarra woman from Nitjpurru, formerly known as Pigeon Hole. She had been struggling with hunting and fishing, with her vision in one eye obscured by cloudy cataracts. "When I go hunting … nice eye I can look, other one no good," she says. Her friends had noticed she sometimes had trouble seeing them too. Now, after her surgery, she's able to read some of the smallest letters on the eye test chart. And she's looking forward to putting her new vision to the test back home. "It's good. We'll go fishing … get barramundi, long ones, and turtles." The eye doctors say while patients in Sydney and Melbourne will sometimes joke that they can now see their wrinkles more clearly, it's common for Indigenous patients in the Top End to talk about things like hunting. "It's always exciting to see the patients smiling when we remove the patch over the eye," surgeon Susith Kulasekara says. "There are so many ways it can improve the patient's quality of life. Often driving, the patients say … and caring for their family." Director of primary health care in the Big Rivers region, Antony King, says cataract surgeries are "immediately rewarding" for patients and staff at the hospital. "It's not something that's seen often," he says. Cataracts are the leading cause of blindness for Indigenous adults and are responsible for a sizeable chunk of the eye health gap. As the clouding of the lens in the eye progresses gradually, often affecting both eyes, many remote patients don't realise how bad their vision has become until they get a visit from a travelling optometrist. And then there are all the challenges of traversing hundreds of kilometres for a surgery, on poor-quality roads that often close during the wet season. Health workforce data shows 1,004 ophthalmologists practising in Australia as of 2023, with only seven of those in the vast Northern Territory. The Indigenous and Remote Eye Service, known as IRIS, is a federally funded program bringing eye surgeons to the outback to tackle the backlog of cases. "The distribution of the clinicians that are needed to deliver these services has contracted in Australia … over a number of decades," Tim Gallagher, chief executive of Brisbane-based Vanguard Health, which delivers the program, says. Mr Gallagher says patients will sometimes be on the waiting list for two to three years before they can be seen. Getting dozens of remote residents to the hospital on one day is an enormous logistical challenge, especially when some people don't use mobile phones and move from place to place. The program has succeeded by performing more than 800 cataract surgeries since mid-2023. It will now attempt to complete a further 800 during the next two years. Dr Kulasekara says word spreads about how straightforward and painless the procedure is when patients return to their community. "They become ambassadors," he says. While most of the IRIS patients are Aboriginal, some are not, such as 83-year-old Katherine resident Peter Wilson. He says the transformation of his vision after having cataracts removed from both eyes has been astonishing. "I just couldn't believe how bright everything was, the colours," he says. Mr Wilson says he does most of the vacuuming around his house but was increasingly missing spots. "I'll be told by my wife, 'That's still a bit dirty, can't you see that?'" he laughs. "So that is the sort of thing that I think will make a difference. I won't miss bits." As fellow patient Mildred Hector leaves to catch her plane back to her community of Nitjpurru, she grabs one of the eye doctors for a parting hug. "Thank you my dear, enjoy your vision," the doctor says.
Globe and Mail
19-05-2025
- Business
- Globe and Mail
Intraocular Lens Market to Witness Upsurge in Growth by 2032, Assesses DelveInsight
DelveInsight's Intraocular Lens Market Insights Report provides the current and forecast market analysis, individual leading Intraocular Lens Companies market shares, challenges, Intraocular Lens Market Drivers, barriers, trends, and key market Intraocular Lens Companies in the market. To read more about the latest highlights related to the Intraocular Lens Market, get a snapshot of the key highlights entailed in the Market Report @ Intraocular Lens Pipeline Products Market Key Takeaways from the Intraocular Lens Pipeline Products Market In April 2025, Berkeley Eye Center conducted a study Comparing Bilateral Clareon PanOptix, Bilateral Clareon PanOptix Pro, and Mixed Clareon PanOptix Pro/Vivity Intraocular Lens Implantation in Cataract Subjects. The Global Intraocular Lens Market was valued at USD 3.85 billion in 2024, growing at a CAGR of 4.89% during the forecast period from 2025 to 2032 to reach USD 5.13 billion by 2032. The Intraocular Lens Companies such as Johnson & Johnson, HOYA GROUP, Alcon Inc, Carl Zeiss Meditec AG, Bausch & Lomb, Rayner Intraocular Lenses Limited, Eyekon Medical Inc, Lenstec, Inc, HumanOptics AG, STAAR Surgical Company, Aurolab, PhyIOL S.A., Care Group, Tekia Inc, Omni Lens Pvt Ltd, MORCHER® GmbH, Ophtec BV, SIFI S.p.A., Excellent Hi-Care Pvt. Ltd., Hanita Lenses and others. To know more about why North America is leading the market growth in the Intraocular Lens Pipeline Products Market, get a snapshot @ Intraocular Lens Market Outlook Intraocular Lens Market Dynamics The intraocular lenses market is experiencing increased product demand for a variety of reasons, one of the main reasons being the increase in the prevalence of ocular diseases. Increasing prevalence of eye diseases such as refractive error, age-related macular degeneration, cataracts, diabetic retinopathy, and glaucoma is a major driver of the intraocular lens market in particular. The majority of people over the age of 60 are affected by various types of eye problems that are chronic and require eye surgery. Visual impairment is a global health problem that affects physical and mental health. Visually impaired people are at particular risk of chronic illness, accidents, social withdrawal, depression, and death. Intraocular Lens Market Segmentation Intraocular Lenses Market by Product Type (Monofocal IOLs [Aspheric Monofocal IOLs and Spheric Monofocal IOLs], Premium IOLs [Multifocal IOLs, Accommodating IOLs, And Extended Depth-Of-Focus IOLs], and Others), by Material (Polymethyl Methacrylate, Hydrophobic Acrylic IOLs, Hydrophilic Acrylic IOLs, and Others), by End User (Hospitals, Ambulatory Surgical Centers, and Ophthalmology Clinics), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World). Get a sneak peek at the Intraocular Lens Pipeline Products Market @ Intraocular Lens Market Dynamics Analysis Intraocular Lens Companies Johnson & Johnson, HOYA GROUP, Alcon Inc, Carl Zeiss Meditec AG, Bausch & Lomb, Rayner Intraocular Lenses Limited, Eyekon Medical Inc, Lenstec, Inc, HumanOptics AG, STAAR Surgical Company, Aurolab, PhyIOL S.A., Care Group, Tekia Inc, Omni Lens Pvt Ltd, MORCHER® GmbH, Ophtec BV, SIFI S.p.A., Excellent Hi-Care Pvt. Ltd., Hanita Lenses and others. Intraocular Lens Market Drivers The demand for intraocular lenses is witnessing a surge primarily due to the rising eye diseases prevalence, increasing initiatives by various governments across the globe in controlling and treating blindness, technological advancements in IOLs, and the increasing geriatric population who are more susceptible to ocular ailments which are expected to contribute in the growing product demand thereby boosting the growth of the of the intraocular lens market during the forecast period from 2025-2032. Which MedTech key players in the Intraocular Lens Pipeline Products Market are set to emerge as the trendsetter explore @ Intraocular Lens Companies Scope of the Intraocular Lens Market Report Coverage- Global Intraocular Lens Companies- Johnson & Johnson, HOYA GROUP, Alcon Inc, Carl Zeiss Meditec AG, Bausch & Lomb, Rayner Intraocular Lenses Limited, Eyekon Medical Inc, Lenstec, Inc, HumanOptics AG, STAAR Surgical Company, Aurolab, PhyIOL S.A., Care Group, Tekia Inc, Omni Lens Pvt Ltd, MORCHER® GmbH, Ophtec BV, SIFI S.p.A., Excellent Hi-Care Pvt. Ltd., Hanita Lenses and others. Intraocular Lens Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World Interested in knowing the Intraocular Lens Market by 2032? Click to get a snapshot of the Intraocular Lens Market Trends Table of Contents 1. Intraocular Lens Market Report Introduction 2. Intraocular Lens Market Executive Summary 3. Regulatory and Patent Analysis 4. Intraocular Lens Market Key Factors Analysis 5. Intraocular Lens Market Porter's Five Forces Analysis 6. COVID-19 Impact Analysis on Intraocular Lens Market 7. Intraocular Lens Market Layout 8. Intraocular Lens Market Global Company Share Analysis – Key 3-5 Companies 9. Intraocular Lens Market Company and Product Profiles 10. KOL Views 11. Project Approach 12. About DelveInsight 13. Disclaimer & Contact Us About Us DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve. Media Contact Company Name: DelveInsight Business Research LLP Contact Person: Yash Bhardwaj Email: Send Email Phone: 09650213330 Address: 304 S. Jones Blvd #2432 City: Las Vegas State: NV Country: United States Website:
